IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	198.85	126.94	91.98
Other Operating Expenses	3.04	1.85	-8.46
Total Operating Expenses	201.9	128.78	83.53
Operating Income	-201.9	-128.78	-83.53
Interest Expense	-1.09	-	-
Interest & Investment Income	114.12	-	-
Currency Exchange Gain (Loss)	0.36	-2.3	-0.15
Other Non-Operating Income	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	175.76	12.76	-
Asset Writedown	909.18	1,478	747.19
Pretax Income	791.71	1,313	611.88
Income Tax Expense	462.95	-	-
Net Income	328.76	1,313	611.88
Net Income to Common	328.76	1,313	611.88
Net Income Growth	-74.95%	114.51%	-
Basic Shares Outstanding	168	168	70
Diluted Shares Outstanding	168	168	70
Shares Change (YoY)	-	139.29%	-
EPS (Basic)	1.96	7.84	8.74
EPS (Diluted)	1.96	7.84	8.74
EPS Growth	-74.95%	-10.36%	-
EBITDA	-200.23	-128.13	-83.47
D&A For Ebitda	1.67	0.65	0.05
EBIT	-201.9	-128.78	-83.53
Effective Tax Rate	58.48%	-	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.